Jigesha Dholakia
Associate Director, Analytical Development QC,
Bayer
Jigesha has been in the cell and gene therapy space for over 15 years, starting off my career in academia working in James Wilson’s lab at the University of Pennsylvania. Since then, She has worked in both process and analytical development roles and companies such as BioMarin, Pfizer and Sangamo Therapeutics. She current lead analytics of a cell therapy drug product at Bayer.
Sessions
-
25-Sep-2024MontereyThe promise and challenges of iPSC-based therapies